Haematological toxicity following different dosing schedules of 5-fluorouracil and epirubicin in rats

被引:0
作者
Simonsen, LE [1 ]
Wählby, U [1 ]
Sandström, M [1 ]
Freijs, A [1 ]
Karlsson, MO [1 ]
机构
[1] Uppsala Univ, Dept Pharm, Div Biopharmaceut & Pharmacokinet, SE-75123 Uppsala, Sweden
关键词
5-fluorouracil; Epirubicin; pharmacokinetics; schedule dependence; haematological toxicity;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To study the effects of single and fractionated doses of 5-fluorouracil and epirubicin on the leukocyte counts in rats. Methods: Six different dosing patterns of each drug were injected within one day. The leukocytes were followed for 11-15 days. Pharmacokinetic models were developed using NONMEM. Quantitative and qualitative pharmacokinetic-pharmacodynamic relationships were investigated Results: A one-compartment model with non-lineal elimination described 5-fluorouracil pharmacokinetics and a three-compartment model described epirubicin concentration data. Sigmoidal or basic E-max-models quantified the relationships between individual AUCs and decreases in leukocytes, for both drugs. Similar relationships between AUC and toxicity were found, regardless of whether the drugs were given as single or fractionated doses. Conclusion: Quantitative relationships between AUC and the effect on leukocytes were established for 5-fluorouracil and epirubicin. However; no schedule dependence was indicated for the schedules used in the study.
引用
收藏
页码:1519 / 1525
页数:7
相关论文
共 25 条
[1]  
AARDAL NP, 1983, EXP HEMATOL, V11, P792
[2]  
Abrahamsen JF, 1997, EUR J HAEMATOL, V58, P333
[3]   PHARMACOKINETICS AND PHARMACODYNAMICS OF LONG-TERM CONTINUOUS-INFUSION DOXORUBICIN [J].
ACKLAND, SP ;
RATAIN, MJ ;
VOGELZANG, NJ ;
CHOI, KE ;
RUANE, M ;
SINKULE, JA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (04) :340-347
[4]  
BEAL SL, 1992, NONMEM USERS GUIDES
[5]   EFFECT OF H-2-RECEPTOR ANTAGONISTS ON THE PHARMACOKINETICS OF 5-FLUOROURACIL IN THE RAT AND MONKEY [J].
DILLOWAY, MR ;
LANT, AF .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1991, 12 (01) :17-28
[6]  
EGORIN MJ, 1986, CANCER RES, V46, P1513
[7]   EUROPEAN-CANADIAN RANDOMIZED TRIAL OF PACLITAXEL IN RELAPSED OVARIAN-CANCER - HIGH-DOSE VERSUS LOW-DOSE AND LONG VERSUS SHORT INFUSION [J].
EISENHAUER, EA ;
HUININK, WWT ;
SWENERTON, KD ;
GIANNI, L ;
MYLES, J ;
VANDERBURG, MEL ;
KERR, I ;
VERMORKEN, JB ;
BUSER, K ;
COLOMBO, N ;
BACON, M ;
SANTABARBARA, P ;
ONETTO, N ;
WINOGRAD, B ;
CANETTA, R .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (12) :2654-2666
[8]  
HARRIS BE, 1989, CANCER RES, V49, P6610
[9]   LIQUID-CHROMATOGRAPHIC ANALYSIS OF ADRIAMYCIN AND METABOLITES IN BIOLOGICAL-FLUIDS [J].
ISRAEL, M ;
PEGG, WJ ;
WILKINSON, PM ;
GARNICK, MB .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1978, 1 (06) :795-809
[10]   A RANDOMIZED STUDY OF EPIRUBICIN AT 4 DIFFERENT DOSE LEVELS IN ADVANCED BREAST-CANCER - FEASIBILITY OF MYELOTOXICITY PREDICTION THROUGH SINGLE BLOOD-SAMPLE MEASUREMENT [J].
JAKOBSEN, P ;
BASTHOLT, L ;
DALMARK, M ;
PFEIFFER, P ;
PETERSEN, D ;
GJEDDE, SB ;
SANDBERG, E ;
ROSE, C ;
NIELSEN, OS ;
MOURIDSEN, HT .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 28 (06) :465-469